Peptide Biologics
Research Use Only

Are you 21 or older?

Our materials are sold strictly for in‑vitro research and laboratory use. Not for human consumption. Please confirm you are 21 years or older to continue.

Free Ship $200+ · cGMP · Lab-Verified
CJC-1295 Ipamorelin – 5/5mg
GH Secretagogues · SKU PB-CJC1295-IPA

CJC-1295 Ipamorelin – 5/5mg

$105.00

Peptide Combination Special Ipamorelin (5mg x 5 Vials) and Mod GRF 1-29 (5mg x 5 Vials)

1
Certificate of Analysis
Lab #203840 · HPLC + MS verified
View CoA Report
cGMP
Manufactured
3rd-Party
Verified
US Lab
Tested
1–2 Day
Shipping
Deeper background on this peptide
Mechanism, references, and protocols on PeptideInstitute.AI

CJC-1295 / Ipamorelin Blend

Primary Application: Dual-Pathway Pituitary Synergy and Accelerated Recovery

Fundamental Information

  • Components: CJC-1295 (No DAC) and Ipamorelin

  • Classification: GHRH Analog (CJC) and Selective Ghrelin Receptor Agonist (Ipamorelin)

  • Mechanism: Dual-pathway pituitary stimulation

  • Primary Benefit: Pulse amplification and duration extension

Detailed Overview

The combination of CJC-1295 and Ipamorelin is one of the most widely researched synergistic peptide duos for optimizing growth hormone production. While both peptides encourage the pituitary gland to release more hormone, they do so through entirely different biological receptors. CJC-1295 mimics the signal from the hypothalamus (GHRH) to start a pulse, while Ipamorelin mimics the hormone ghrelin to amplify that pulse and block somatostatin—the body’s “brake” hormone that usually stops growth hormone release.

Studies suggest that when these two peptides are used together, they produce a synergistic effect that can result in a 3-fold to 5-fold increase in growth hormone output compared to using either peptide alone. This “nudge and amplify” approach is highly valued in research for its ability to improve muscle fiber development, accelerate fat loss through lipolysis, and enhance collagen production for joint health. Notably, the blend is researched for its high safety profile; Ipamorelin is highly selective and does not cause the spikes in cortisol (stress) or prolactin (appetite/mood) that are common with older growth-stimulating compounds. This makes the blend a centerpiece of research into long-term hormone optimization and healthy aging.

Scientific References

  1. Perez B. “The Mechanism of Action and Synergy of CJC-1295 And Ipamorelin Peptide Blend.” Iconic Research And Engineering Journals. 2026.

  2. Alba M, et al. “Partial reversibility of growth hormone (GH) deficiency in the GH-releasing hormone (GHRH) knockout mouse by postnatal treatment with a GHRH analog.” Endocrinology. 2005.

  3. Ionescu M, Frohman LA. “Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295.” Journal of Clinical Endocrinology and Metabolism. 2006.